Russian company invests 280 million rub in the production of medical glass
01 April 2024
An enterprise in the Kabardino-Balkarian Republic, the Chegem Glass Factory, is planning to ramp up its production of medical glass to 300 million bottles per year by September 2024, up from its current capacity of 170 million pieces. For this purpose, a second line will be launched at the facility. For these purposes, 280 million rubles will be required.
India is the leader among countries importing medicines to the Russian Federation
01 April 2024
At the end of 2023, India topped the ranking of countries supplying medicines to Russia. Previously, Germany occupied the first place on this list (2021 and 2022). The top five countries are France, Hungary and the Republic of Belarus. RBC draws information from a report by the analytical firm RNC Pharma. During the study, analysts compared their own data and information from Roszdravnadzor on the release of drugs into circulation.
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian Prime Minister Mikhail Mishustin signed Decree No. 371 on March 23, 2024, which expands the parameters of the compulsory health insurance program for the year 2024 as well as for the planning period of 2025 and 2026.
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
Scientists from the Saint Petersburg Scientific Research Institute of Phthisiopulmonology and the Research Institute of Influenza have developed new vaccines against tuberculosis. According to the director of the St. Petersburg Research Institute of Physics, Peter Yablonsky, two developments are ready for clinical trials: parenteral and nasal prophylactic drugs.
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
The Deputy Minister of Health of the Russian Federation, Evgeny Kamkin, announced that the overall mortality rate of Russians in 2023 has decreased by an impressive 7%. As specified, this is the best indicator since the COVID-19 pandemic.
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024
Hungary, Serbia, and Russia have agreed to collaborate on joint projects in the field of nuclear medical technologies, focusing on cancer treatment. This agreement was reached during the international forum Atomexpo-2024, held in Sochi.
Researchers propose novel test for pyrogen detection
27 March 2024
An alternative in vitro pyrogen detection test using transfected THP-1 cells detected endotoxin and nonendotoxin pyrogens with good sensitivity, stability and predictability, a study shows.
Parkinson’s infusion treatment demonstrates advantage over oral delivery
27 March 2024
A Phase III trial has shown that compared to oral drug delivery, administering levodopa through an infusion pump led to nearly two hours of day (1.72) of additional time in which the medicine reduced symptoms in Parkinson’s patients.
Innate drops monotherapy plans for lacutamab in one type of lymphoma after hold lift
26 March 2024
Just two months after the FDA lifted a clinical hold on trials of Innate Pharma’s lymphoma drug, the biotech has now dropped plans to pursue the anti-KIR3DL2 antibody as a monotherapy for a specific form of that cancer.
Control strategy could facilitate faster bioburden detection
26 March 2024
Biopharma and bioprocessing experts have proposed an approach that uses a two-tiered control strategy for rapid bioburden testing, that can beneficially, “leverage faster detection times”. It comprises of a “fast (but possibly less sensitive) test” for process monitoring which then initiates “action for a second, longer duration test which is used to confirm and quantify the presence of bioburden and identify the [ microbial ] organism.”
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024